Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-15-003092
Filing Date
2015-04-30
Accepted
2015-04-30 16:00:29
Documents
3
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ctic-10ka_20141231.htm 10-K/A 1584288
2 EX-31.1 ctic-ex311_20141231158.htm EX-31.1 7463
3 EX-31.2 ctic-ex312_20141231159.htm EX-31.2 8599
  Complete submission text file 0001564590-15-003092.txt   1601461
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12465 | Film No.: 15818316
SIC: 2834 Pharmaceutical Preparations